financetom
Business
financetom
/
Business
/
-- InterRent REIT Brief: Keeps Outperform But Target Eased To C$14.50 From $15 at National Bank, Which Notes "In-line on higher NOI margin" For Q3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- InterRent REIT Brief: Keeps Outperform But Target Eased To C$14.50 From $15 at National Bank, Which Notes "In-line on higher NOI margin" For Q3
Nov 7, 2024 1:11 AM

02:45 PM EST, 11/05/2024 (MT Newswires) --

Price: 11.20, Change: -0.05, Percent Change: -0.44

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guardant Health's Shield Blood Test Approved by FDA; Shares Rise Pre-Bell
Guardant Health's Shield Blood Test Approved by FDA; Shares Rise Pre-Bell
Jul 29, 2024
08:45 AM EDT, 07/29/2024 (MT Newswires) -- Guardant Health ( GH ) said Monday the US Food and Drug Administration has approved its Shield blood test for colorectal cancer screening in adults aged 45 years and older. The company said the blood test is the first to be approved by the FDA as a primary screening option for colorectal cancer...
Brown & Brown to Acquire Quintes Holding
Brown & Brown to Acquire Quintes Holding
Jul 29, 2024
08:48 AM EDT, 07/29/2024 (MT Newswires) -- Brown & Brown ( BRO ) said Monday that it has agreed to acquire Quintes Holding from private investment firm Aquiline Capital Partners and the Quintes management ownership team. Quintes, an independent insurance broker in the Netherlands, will continue to be headed by founder and chief executive Gijsbert van de Nieuwegiessen, Brown &...
Enova International to Offer $400 Million of Senior Notes due 2029
Enova International to Offer $400 Million of Senior Notes due 2029
Jul 29, 2024
08:47 AM EDT, 07/29/2024 (MT Newswires) -- Enova International ( ENVA ) said Monday it plans to sell $400 million in senior notes due 2029 in a private offering. Proceeds from the sale will be used to fund a tender offer for Enova's ( ENVA ) 8.500% senior notes due 2025 and for general corporate purposes the company said. Enova...
Correction: Integra LifeSciences Q2 Adjusted Earnings Fall, Revenue Rises; Lowers 2024 Outlook
Correction: Integra LifeSciences Q2 Adjusted Earnings Fall, Revenue Rises; Lowers 2024 Outlook
Jul 29, 2024
08:47 AM EDT, 07/29/2024 (MT Newswires) -- (Corrects the revenue change in the headline.) Integra LifeSciences Holdings ( IART ) reported Q2 adjusted earnings Monday of $0.63 per diluted share, down from $0.71 a year earlier. Analysts polled by Capital IQ expected $0.62. Revenue for the quarter ended June 30 was $418.2 million, up from $381.3 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved